You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 16, October 24, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (52)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Conflict of Interest
 •Medical Ethics
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior

Brendan B. McCormick, MD; George Tomlinson, PhD; Patrick Brill-Edwards, MD; Allan S. Detsky, MD, PhD

JAMA. 2001;286:1994-1999.

Context  The long-term effect of policies restricting contact between residents and pharmaceutical company representatives (PCRs) during internal medicine training is unknown. The McMaster University Department of Medicine in Hamilton, Ontario, implemented a policy restricting PCR contact with trainees in 1992, whereas the Department of Medicine at the University of Toronto, Toronto, Ontario, has no such policy.

Objective  To determine if the presence of a restrictive policy and the frequency of contact with PCRs during internal medicine training predict attitudes and behavior several years after completion of training.

Design, Setting, and Participants  Retrospective analysis of the attitudes and behavior of 3 cohorts of physicians: University of Toronto trainees, prepolicy McMaster trainees, and postpolicy McMaster trainees. Surveys were mailed to 242 former University of Toronto and 57 former McMaster trainees who completed their internal medicine training between 1990 and 1996, with response rates of 163 (67%) and 42 (74%), respectively.

Main Outcome Measures  Physician attitude, assessed by a question about the perceived helpfulness of PCR information, and behavior, assessed by whether physicians met with PCRs in the office and the frequency of contacts with PCRs (current contact score, consisting of conversations with PCRs, PCR-sponsored events attended, gifts, honoraria, and consulting fees received).

Results  In both the unadjusted and multiple regression analyses, postpolicy McMaster trainees were less likely to find information from PCRs beneficial in guiding their practice compared with Toronto and prepolicy McMaster trainees, with unadjusted odds ratios (ORs) of 0.44 (95% confidence interval [CI], 0.20-0.94) and 0.39 (95% CI, 0.13-1.22), respectively. All 3 groups were equally likely to report that they met with PCRs in their office in the past year (88%). Postpolicy McMaster trainees had a lower current contact score compared with Toronto (9.3 vs 10.9; P = .04) and prepolicy McMaster trainees (9.3 vs 10.8; P = .18). In multiple regression models, greater frequency of contact with PCRs during training was a predictor of increased perceived benefit of PCR information (OR, 1.29; 95% CI, 1.13-1.47) and was positively correlated with the current contact score (partial r = 0.49; P<.001). Number of PCR-sponsored rounds attended during training was not a consistent predictor of attitudes or behavior.

Conclusions  Policies restricting PCR access to internal medicine trainees and the amount of contact during residency appear to affect future attitudes and behavior of physicians.


Author Affiliations: University of Toronto, Departments of Health Policy, Management, and Evaluation, and Medicine, Department of Medicine, Mount Sinai Hospital and University Health Network, Toronto (Drs McCormick, Tomlinson, and Detsky); and Department of Medicine, McMaster University, Hamilton (Dr Brill-Edwards), Ontario.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Pharmaceutical Representatives and Resident Physicians
James L. Glazer
JAMA. 2002;287(7):844.
EXTRACT | FULL TEXT  

RELATED ARTICLE

October 24/31, 2001
JAMA. 2001;286(16):2033-2034.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Everyone's a Little Bit Biased (Even Physicians)
Cain and Detsky
JAMA 2008;299:2893-2895.
FULL TEXT  

To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?
Carroll et al.
Pediatrics 2007;120:e1528-e1535.
ABSTRACT | FULL TEXT  

Encouraging medical students to do research and write papers
Detsky and Detsky
CMAJ 2007;176:1719-1721.
FULL TEXT  

Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry
Pinto et al.
J. Med. Ethics 2007;33:313-319.
ABSTRACT | FULL TEXT  

Interactions Between Physicians and Industry: A Guide for Clinicians
Jibson
Focus 2007;5:398-406.
ABSTRACT | FULL TEXT  

Patent nonsense: Evidence tells of an industry out of social control.
Mintzberg
CMAJ 2006;175:374-374.
FULL TEXT  

Academic medical centers and conflicts of interest.
Watson et al.
JAMA 2006;295:2847-2848.
FULL TEXT  

The Role of the Pharmaceutical Industry in Medical Education in Psychiatry
Lazarus
Acad. Psychiatry 2006;30:40-44.
FULL TEXT  

Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers
Brennan et al.
JAMA 2006;295:429-433.
ABSTRACT | FULL TEXT  

The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior
Huang et al.
Acad. Psychiatry 2005;29:500-501.
FULL TEXT  

Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey
Sierles et al.
JAMA 2005;294:1034-1042.
ABSTRACT | FULL TEXT  

Managing Febrile Infants: Impact of Literature Recommendations Published During a Physician's Residency
Cox et al.
Eval Health Prof 2005;28:328-348.
ABSTRACT  

Psychiatric Training Program Engagement With the Pharmaceutical Industry: An Educational Issue, Not Strictly an Ethical One
Mohl
Acad. Psychiatry 2005;29:215-221.
ABSTRACT | FULL TEXT  

The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
Brodkey
Acad. Psychiatry 2005;29:222-229.
ABSTRACT | FULL TEXT  

A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry
Varley et al.
Acad. Psychiatry 2005;29:40-46.
ABSTRACT | FULL TEXT  

The role of the pharmaceutical industry in neurologic education
Gelb
Neurology 2005;64:E7-E10.
FULL TEXT  

Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto
Ferris et al.
J. Med. Ethics 2004;30:25-29.
ABSTRACT | FULL TEXT  

Medical Education and Corporate Sponsorship
Capozzi et al.
JBJS 2003;85:168-170.
ABSTRACT | FULL TEXT  

Long-Term Effects of Restricting Residents' Contacts with Drug Representatives
Comerci
AAP Grand Rounds 2002;7:32-32.
FULL TEXT  

Pharmaceutical Representatives and Resident Physicians
Glazer
JAMA 2002;287:844-844.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.